Quick Answer
TG THERAPEUTICS, INC. reported Operating Income of $123.32 million for fiscal year 2025.
TG THERAPEUTICS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $123.32M | +194.1% |
| 2024 | $41.93M | +103.2% |
| 2023 | $20.63M | +109.5% |
| 2022 | -$218.32M | +36.7% |
| 2021 | -$344.77M | -26.0% |
| 2020 | -$273.59M | -61.8% |
| 2019 | -$169.06M | +3.1% |
| 2018 | -$174.40M | -46.9% |
| 2017 | -$118.71M | -50.3% |
| 2016 | -$78.97M | -25.0% |
| 2015 | -$63.18M | -13.4% |
| 2014 | -$55.72M | -142.6% |
| 2013 | -$22.97M | +14.6% |
| 2012 | -$26.90M | -2949.4% |
| 2011 | -$882.0K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $29.36M | +136.2% | -15.7% |
| June 30, 2025 | $34.84M | +295.2% | +304.1% |
| March 31, 2025 | $8.62M | +193.0% | -30.7% |
| September 30, 2024 | $12.43M | -89.2% | +41.0% |
| June 30, 2024 | $8.82M | +119.7% | +195.1% |
| March 31, 2024 | -$9.27M | +74.9% | -108.1% |
| September 30, 2023 | $114.78M | +428.3% | +356.9% |
| June 30, 2023 | -$44.67M | -14.7% | -20.8% |
- TG THERAPEUTICS, INC. showed an increase of +194.1% in Operating Income compared to the prior fiscal year.
- Over the 2011–2025 period, TG THERAPEUTICS, INC.’s operating income has grown by 14082.7% (from -$882.0 thousand to $123.32 million).
- The most recent figure is from TG THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: